July 12, 2021

 

Via EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention: David Gessert

Laura Crotty

Jenn Do

Daniel Gordon

 

          Re:        Rapid Micro Biosystems, Inc.
         Registration Statement on Form S-1
         Filed July 12, 2021
         Registration No. 333-257431

 

  Acceleration Request

 

Requested Date:             July 14, 2021

Requested Time:            4:00 p.m., Eastern Time

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several underwriters, hereby join Rapid Micro Biosystems, Inc. in requesting that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-257431) (the “Registration Statement”) to become effective on Wednesday, July 14, 2021, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter.

 

Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

 

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.

 

[Signature Page Follows]

 

 

 

	Very truly yours,
	J.P. MORGAN SECURITIES LLC

 

	By:	/s/ Kyle Finegan
		Name: Kyle Finegan
		Title: Executive Director

 

MORGAN STANLEY & CO. LLC

 

	By:	/s/ Chris Rigoli
		Name: Chris Rigoli
		Title: Vice President

 

COWEN AND COMPANY, LLC

 

	By:	/s/ Adam Chazan
		Name: Adam Chazan
		Title: Managing Director

 

STIFEL, NICOLAUS & COMPANY, INCORPORATED

 

	By:	/s/ Nathan Thomson
		Name: Nathan Thomson
		Title: Director

 

cc:	Robert Spignesi, Rapid Micro Biosystems, Inc.
	Wesley Holmes, Latham & Watkins LLP
	Edwin M. O’Connor, Goodwin Procter LLP

 

[Signature Page to Acceleration Request]